Giorgia Guglielmi
Oncology, Gastroenterology
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Gastroenterology
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Dermatology
Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.
Gastroenterology, Scientific research
Even small differences between strains of gut bacteria—often within the same species—can sway how these microbes interact with the human body and influence disease outcomes.
Oncology
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
Gastroenterology
TCA can help to manage IBD by supporting the gut barrier and influencing microbiota composition.
Pneumology, Pediatrics
The findings of a recent study highlight the importance of early-life gut microbes in shaping lung health and add to evidence that microbiota composition can influence asthma risk.
Scientific research
Altered gut bacteria may contribute to fibromyalgia and modifying the gut microbiota could offer a promising approach to reduce symptoms of the condition.
Pediatrics
The gut microbiota evolves throughout early life, especially during key transitions phases such as weaning.
Scientific research
A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.